Latest Cancer immunotherapy Stories
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma.
A promising, new cancer immunotherapy combination treatment showing long term survival for patients with metastatic melanoma was highlighted today at the American Society of Clinical Oncology
Additional Data Released at ASCO Annual Meeting Shows More Promising Results for Immunotherapy as a Treatment Option in Melanoma Chicago, IL (PRWEB) June 02,
FDA Review in SITC's Journal for ImmunoTherapy of Cancer offers new insights into cancer immunotherapy product development & clinical evaluation. Milwaukee,
Cancer cells spread and grow by avoiding detection and destruction by the immune system.
- In medieval musical notation, a sign or neume denoting a shake or trill.